• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jonathan A. Fletcher, MD

Publications

  • Yeh CN, Yen CC, Chen YY, Cheng CT, Huang SC, Chang TW, Yao FY, Lin YC, Wen YS, Chiang KC, Chen JS, Yeh TS, Tzeng CH, Chao TC, Fletcher JA.Identification of aurora kinase A as an unfavorable prognostic factor and potential treatment target for metastatic gastrointestinal stromal tumors.Oncotarget. 2014 May 23.
    24901229
  • Wang Y, Marino-Enriquez A, Bennett RR, Zhu M, Shen Y, Eilers G, Lee JC, Henze J, Fletcher BS, Gu Z, Fox EA, Antonescu CR, Fletcher CD, Guo X, Raut CP, Demetri GD, van de Rijn M, Ordog T, Kunkel LM, Fletcher JA.Dystrophin is a tumor suppressor in human cancers with myogenic programs.Nat Genet. 2014 Jun;46(6):601-6.
    24793134
  • Kohsaka S, Shukla N, Ameur N, Ito T, Ng CK, Wang L, Lim D, Marchetti A, Viale A, Pirun M, Socci ND, Qin LX, Sciot R, Bridge J, Singer S, Meyers P, Wexler LH, Barr FG, Dogan S, Fletcher JA, Reis-Filho JS, Ladanyi M.A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.Nat Genet. 2014 Jun;46(6):595-600.
    24793135
  • Sioletic S, Czaplinski J, Hu L, Fletcher JA, Fletcher CD, Wagner AJ, Loda M, Demetri GD, Sicinska ET, Snyder EL.c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.J Pathol. 2014 May 22.
    24852265
  • Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P.VCL-ALK Renal Cell Carcinoma in Children With Sickle-cell Trait: The Eighth Sickle-cell Nephropathy?.Am J Surg Pathol. 2014 Apr 2.
    24698962
  • Maynard MA, Marino-Enriquez A, Fletcher JA, Dorfman DM, Raut CP, Yassa L, Guo C, Wang Y, Dorfman C, Feldman HA, Frates MC, Song H, Jugo RH, Taguchi T, Hershman JM, Larsen PR, Huang SA.Thyroid hormone inactivation in gastrointestinal stromal tumors.N Engl J Med. 2014 Apr 3;370(14):1327-34.
    24693892
  • Serrano C, Wang Y, Mariño-Enríquez A, Lee JC, Ravegnini G, Morgan JA, Bertagnolli MM, Beadling C, Demetri GD, Corless CL, Heinrich MC, Fletcher JA.KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation.J Clin Oncol. 2014 Mar 31.
    24687822
  • Yen CC, Hsiao CD, Chen WM, Wen YS, Lin YC, Chang TW, Yao FY, Hung SC, Wang JY, Chiu JH, Wang HW, Lin CH, Chen TH, Chen PC, Liu CL, Tzeng CH, Fletcher JA.Cytotoxic effects of 15d-PGJ2 against osteosarcoma through ROS-mediated AKT and cell cycle inhibition.Oncotarget. 2014 Feb 15;5(3):716-25.
    24566468
  • Lee CH, Hoang LN, Yip S, Reyes C, Marino-Enriquez A, Eilers G, Tao D, Chiang S, Fletcher JA, Soslow RA, Nucci MR, Oliva E.Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement.Mod Pathol. 2013 Nov 1.
    24186140
  • Hayashi Y, Asuzu DT, Gibbons SJ, Aarsvold KH, Bardsley MR, Lomberk GA, Mathison AJ, Kendrick ML, Shen KR, Taguchi T, Gupta A, Rubin BP, Fletcher JA, Farrugia G, Urrutia RA, Ordog T.Membrane-to-nucleus signaling links insulin-like growth factor-1- and stem cell factor-activated pathways.PLoS ONE. 2013;8(10):e76822.
    24116170
  • Hodi FS, Corless CL, Giobbie-Hurder A, Fletcher JA, Zhu M, Marino-Enriquez A, Friedlander P, Gonzalez R, Weber JS, Gajewski TF, O'Day SJ, Kim KB, Lawrence D, Flaherty KT, Luke JJ, Collichio FA, Ernstoff MS, Heinrich MC, Beadling C, Zukotynski KA, Yap JT, Van den Abbeele AD, Demetri GD, Fisher DE.Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin.J Clin Oncol. 2013 Sep 10;31(26):3182-90.
    23775962
  • Angelini S, Ravegnini G, Fletcher JA, Maffei F, Hrelia P.Clinical relevance of pharmacogenetics in gastrointestinal stromal tumor treatment in the era of personalized therapy.Pharmacogenomics. 2013 Jun;14(8):941-56.
    23746188
  • Lynn M, Wang Y, Slater J, Shah N, Conroy J, Ennis S, Morris T, Betts DR, Fletcher JA, O'Sullivan MJ.High-resolution Genome-wide Copy-number Analyses Identify Localized Copy-number Alterations in Ewing Sarcoma.Diagn Mol Pathol. 2013 Jun;22(2):76-84.
    23628818
  • Simon S, Grabellus F, Ferrera L, Galietta LJ, Schwindenhammer B, Muehlenberg T, Taeger G, Eilers G, Treckmann J, Breitenbuecher F, Schuler M, Taguchi T, Fletcher JA, Bauer S.DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors.Cancer Res. 2013 Apr 16.
    23576565
  • Katz SC, Burga RA, Naheed S, Licata LA, Thorn M, Osgood D, Nguyen CT, Espat NJ, Fletcher JA, Junghans RP.Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor.J Transl Med. 2013;11:46.
    23433424
  • Edris B, Willingham SB, Weiskopf K, Volkmer AK, Volkmer JP, Mühlenberg T, Montgomery KD, Contreras-Trujillo H, Czechowicz A, Fletcher JA, West RB, Weissman IL, van de Rijn M.Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth.Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3501-6.
    23382202
  • Floris G, Wozniak A, Sciot R, Li H, Friedman L, Van Looy T, Wellens J, Vermaelen P, Deroose CM, Fletcher JA, Debiec-Rychter M, Schöffski P.A potent combination of the novel PI3K Inhibitor, GDC-0941, with imatinib in gastrointestinal stromal tumor xenografts: long-lasting responses after treatment withdrawal.Clin Cancer Res. 2013 Feb 1;19(3):620-30.
    23231951
  • Ravegnini G, Mariño-Enriquez A, Slater J, Eilers G, Wang Y, Zhu M, Nucci MR, George S, Angelini S, Raut CP, Fletcher JA.MED12 mutations in leiomyosarcoma and extrauterine leiomyoma.Mod Pathol. 2012 Dec 7.
    23222489
  • Lee CH, Ali RH, Rouzbahman M, Marino-Enriquez A, Zhu M, Guo X, Brunner AL, Chiang S, Leung S, Nelnyk N, Huntsman DG, Blake Gilks C, Nielsen TO, Dal Cin P, van de Rijn M, Oliva E, Fletcher JA, Nucci MR.Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.Am J Surg Pathol. 2012 Oct;36(10):1562-70.
    22982899
  • Yen CC, Yeh CN, Cheng CT, Jung SM, Huang SC, Chang TW, Jan YY, Tzeng CH, Chao TC, Chen YY, Yang CY, Ho CL, Fletcher JA.Integrating bioinformatics and clinicopathological research of gastrointestinal stromal tumors: identification of aurora kinase A as a poor risk marker.Ann Surg Oncol. 2012 Oct;19(11):3491-9.
    22588468
  • Wu X, Li J, Zhu M, Fletcher JA, Hodi FS.Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways.Mol Cancer Ther. 2012 Sep;11(9):1905-14.
    22653968
  • Edris B, Fletcher JA, West RB, van de Rijn M, Beck AH.Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.Sarcoma. 2012;2012:805614.
    22919280
  • Smyth T, Van Looy T, Curry JE, Rodriguez-Lopez AM, Wozniak A, Zhu M, Donsky R, Morgan JG, Mayeda M, Fletcher JA, Schöffski P, Lyons J, Thompson NT, Wallis NG.The HSP90 inhibitor, AT13387, is effective against imatinib-sensitive and -resistant gastrointestinal stromal tumor models.Mol Cancer Ther. 2012 Aug;11(8):1799-808.
    22714264
  • Heinrich MC, Marino-Enriquez A, Presnell A, Donsky RS, Griffith DJ, McKinley A, Patterson J, Taguchi T, Liang CW, Fletcher JA.Sorafenib inhibits many kinase mutations associated with drug-resistant gastrointestinal stromal tumors.Mol Cancer Ther. 2012 Aug;11(8):1770-80.
    22665524
  • George S, Wang Q, Heinrich MC, Corless CL, Zhu M, Butrynski JE, Morgan JA, Wagner AJ, Choy E, Tap WD, Yap JT, Van den Abbeele AD, Manola JB, Solomon SM, Fletcher JA, von Mehren M, Demetri GD.Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial.J Clin Oncol. 2012 Jul 1;30(19):2401-7.
    22614970
  • Henze J, Mühlenberg T, Simon S, Grabellus F, Rubin B, Taeger G, Schuler M, Treckmann J, Debiec-Rychter M, Taguchi T, Fletcher JA, Bauer S.p53 modulation as a therapeutic strategy in gastrointestinal stromal tumors.PLoS ONE. 2012;7(5):e37776.
    22662219
  • Lee CH, Mariño-Enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-Rychter M, Cin PD, Fletcher JA, Nucci MR.The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor.Am J Surg Pathol. 2012 Mar 27.
    22456610
  • Edris B, Weiskopf K, Volkmer AK, Volkmer JP, Willingham SB, Contreras-Trujillo H, Liu J, Majeti R, West RB, Fletcher JA, Beck AH, Weissman IL, van de Rijn M.Antibody therapy targeting the CD47 protein is effective in a model of aggressive metastatic leiomyosarcoma.Proc Natl Acad Sci U S A. 2012 Mar 26.
    22451919
  • Edris B, Espinosa I, Mühlenberg T, Mikels A, Lee CH, Steigen SE, Zhu S, Montgomery KD, Lazar AJ, Lev D, Fletcher JA, Beck AH, West RB, Nusse R, van de Rijn M.ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour.J Pathol. 2012 Jan 4.
    22294416
  • Lee CH, Ou WB, Mariño-Enriquez A, Zhu M, Mayeda M, Wang Y, Guo X, Brunner AL, Amant F, French CA, West RB, McAlpine JN, Gilks CB, Yaffe MB, Prentice LM, McPherson A, Jones SJ, Marra MA, Shah SP, van de Rijn M, Huntsman DG, Dal Cin P, Debiec-Rychter M, Nucci MR, Fletcher JA.14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.Proc Natl Acad Sci U S A. 2012 Jan 17;109(3):929-34.
    22223660
  • Wu X, Zhu M, Fletcher JA, Giobbie-Hurder A, Hodi FS.The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.PLoS ONE. 2012;7(1):e29622.
    22253748
  • Gutierrez A, Snyder EL, Marino-Enriquez A, Zhang YX, Sioletic S, Kozakewich E, Grebliunaite R, Ou WB, Sicinska E, Raut CP, Demetri GD, Perez-Atayde AR, Wagner AJ, Fletcher JA, Fletcher CD, Look AT.Aberrant AKT activation drives well-differentiated liposarcoma.Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16386-91.
    21930930
  • Ligon AH, Morton CC, Bieber FR, Fletcher JA, Giersch AB, Kantarci S, Leach N, Lee C, Sandstrom M, Weremowicz S, Xiao S, Dal Cin P.Reporting of diagnostic cytogenetic results.Curr Protoc Hum Genet. 2011 Jul;Appendix 1:1D.
    21735374
  • Ou WB, Hubert C, Corson JM, Bueno R, Flynn DL, Sugarbaker DJ, Fletcher JA.Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.Neoplasia. 2011 Jan;13(1):12-22.
    21245936
  • Mariño-Enríquez A, Ou WB, Weldon CB, Fletcher JA, Pérez-Atayde AR.ALK rearrangement in sickle cell trait-associated renal medullary carcinoma.Genes Chromosomes Cancer. 2011 Mar;50(3):146-53.
    21213368
  • Janeway KA, Kim SY, Lodish M, Nosé V, Rustin P, Gaal J, Dahia PL, Liegl B, Ball ER, Raygada M, Lai AH, Kelly L, Hornick JL, , O'Sullivan M, de Krijger RR, Dinjens WN, Demetri GD, Antonescu CR, Fletcher JA, Helman L, Stratakis CA.Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):314-8.
    21173220
  • Chi P, Chen Y, Zhang L, Guo X, Wongvipat J, Shamu T, Fletcher JA, Dewell S, Maki RG, Zheng D, Antonescu CR, Allis CD, Sawyers CL.ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours.Nature. 2010 Oct 14;467(7317):849-53.
    20927104
  • Ligon AH, Morton CC, Bieber FR, Fletcher JA, Giersch AB, Kantarci S, Leach N, Lee C, Sandstrom M, Weremowicz S, Xiao S, Dal Cin P.Reporting of diagnostic cytogenetic results.Curr Protoc Hum Genet. 2010 Oct;Appendix 1:1D.1-23.
    20891028
  • Janeway KA, Zhu MJ, Barretina J, Perez-Atayde A, Demetri GD, Fletcher JA.Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification.Int J Cancer. 2010 Dec 1;127(11):2718-22.
    20162573
  • Rossi S, Gasparotto D, Toffolatti L, Pastrello C, Gallina G, Marzotto A, Sartor C, Barbareschi M, Cantaloni C, Messerini L, Bearzi I, Arrigoni G, Mazzoleni G, Fletcher JA, Casali PG, Talamini R, Maestra R, Dei Tos AP.Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size.Am J Surg Pathol. 2010 Oct;34(10):1480-91.
    20861712
  • Agoston AT, Liang CW, Richkind KE, Fletcher JA, Vargas SO.Trisomy 18 is a consistent cytogenetic feature in pilomatricoma.Mod Pathol. 2010 Aug;23(8):1147-50.
    20495544
  • Weisberg E, Choi HG, Ray A, Barrett R, Zhang J, Sim T, Zhou W, Seeliger M, Cameron M, Azam M, Fletcher JA, Debiec-Rychter M, Mayeda M, Moreno D, Kung AL, Janne PA, Khosravi-Far R, Melo JV, Manley P, Adamia S, Wu C, Gray N, Griffin JD.Discovery of a small molecule type II inhibitor of wild-type and gatekeeper mutants of BCR-ABL, PDGFR{alpha}, Kit, and Src kinases.Blood. 2010 May 27;115(21):4206-16.
    20299508
  • Parkkila S, Lasota J, Fletcher JA, Ou WB, Kivelä AJ, Nuorva K, Parkkila AK, Ollikainen J, Sly WS, Waheed A, Pastorekova S, Pastorek J, Isola J, Miettinen M.Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors.Mod Pathol. 2010 May;23(5):743-50.
    20081808
  • Sadow PM, Heinrich MC, Corless CL, Fletcher JA, Nosé V.Absence of BRAF, NRAS, KRAS, HRAS Mutations, and RET/PTC Gene Rearrangements Distinguishes Dominant Nodules in Hashimoto Thyroiditis from Papillary Thyroid Carcinomas.Endocr Pathol. 2010 Jun;21(2):73-9.
    20012784
  • Liegl-Atzwanger B, Fletcher JA, Fletcher CD.Gastrointestinal stromal tumors.Virchows Arch. 2010 Feb;456(2):111-27. Review.
    20165865
  • Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, Barretina J, Boehm JS, Dobson J, Urashima M, Mc Henry KT, Pinchback RM, Ligon AH, Cho YJ, Haery L, Greulich H, Reich M, Winckler W, Lawrence MS, Weir BA, Tanaka KE, Chiang DY, Bass AJ, Loo A, Hoffman C, Prensner J, Liefeld T, Gao Q, Yecies D, Signoretti S, Maher E, Kaye FJ, Sasaki H, Tepper JE, Fletcher JA, Tabernero J, Baselga J, Tsao MS, Demichelis F, Rubin MA, Janne PA, Daly MJ, Nucera C, Levine RL, Ebert BL, Gabriel S, Rustgi AK, Antonescu CR, Ladanyi M, Letai A, Garraway LA, Loda M, Beer DG, True LD, Okamoto A, Pomeroy SL, Singer S, Golub TR, Lander ES, Getz G, Sellers WR, Meyerson M.The landscape of somatic copy-number alteration across human cancers.Nature. 2010 Feb 18;463(7283):899-905.
    20164920
  • Bauer S, Parry JA, Mühlenberg T, Brown MF, Seneviratne D, Chatterjee P, Chin A, Rubin BP, Kuan SF, Fletcher JA, Duensing S, Duensing A.Proapoptotic activity of bortezomib in gastrointestinal stromal tumor cells.Cancer Res. 2010 Jan 1;70(1):150-9.
    20028860
  • Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M.Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours.J Pathol. 2010 Jan;220(1):58-70.
    19890883
  • MacConaill LE, Campbell CD, Kehoe SM, Bass AJ, Hatton C, Niu L, Davis M, Yao K, Hanna M, Mondal C, Luongo L, Emery CM, Baker AC, Philips J, Goff DJ, Fiorentino M, Rubin MA, Polyak K, Chan J, Wang Y, Fletcher JA, Santagata S, Corso G, Roviello F, Shivdasani R, Kieran MW, Ligon KL, Stiles CD, Hahn WC, Meyerson ML, Garraway LA.Profiling critical cancer gene mutations in clinical tumor samples.PLoS ONE. 2009;4(11):e7887.
    19924296
  • Razis E, Selviaridis P, Labropoulos S, Norris JL, Zhu MJ, Song DD, Kalebic T, Torrens M, Kalogera-Fountzila A, Karkavelas G, Karanastasi S, Fletcher JA, Fountzilas G.Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.Clin Cancer Res. 2009 Oct 1;15(19):6258-66.
    19789313
  • Demetri GD, Heinrich MC, Fletcher JA, Fletcher CD, Van den Abbeele AD, Corless CL, Antonescu CR, George S, Morgan JA, Chen MH, Bello CL, Huang X, Cohen DP, Baum CM, Maki RG.Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure.Clin Cancer Res. 2009 Sep 15;15(18):5902-9.
    19737946
  • Mühlenberg T, Zhang Y, Wagner AJ, Grabellus F, Bradner J, Taeger G, Lang H, Taguchi T, Schuler M, Fletcher JA, Bauer S.Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumors.Cancer Res. 2009 Sep 1;69(17):6941-50.
    19706776
  • Yen CC, Chen WM, Chen TH, Chen WY, Chen PC, Chiou HJ, Hung GY, Wu HT, Wei CJ, Shiau CY, Wu YC, Chao TC, Tzeng CH, Chen PM, Lin CH, Chen YJ, Fletcher JA.Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma.Int J Oncol. 2009 Oct;35(4):775-88.
    19724913
  • Factor RE, Dal Cin P, Fletcher JA, Cibas ES.Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma.Cancer Cytopathol. 2009 Aug 25;117(4):247-53.
    19536878
  • Gunaratnam M,Swank S,Haider SM,Galesa K,Reszka AP,Beltran M,Cuenca F,Fletcher JA,Neidle S.Targeting Human Gastrointestinal Stromal Tumor Cells with a Quadruplex-Binding Small Molecule.J Med Chem. 2009 Jun 25;52(12):3774-83.
    19469547
  • Snyder EL,Sandstrom DJ,Law K,Fiore C,Sicinska E,Brito J,Bailey D,Fletcher JA,Loda M,Rodig SJ,Dal Cin P,Fletcher CD.c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme.J Pathol. 2009 Jul;218(3):292-300.
    19449367
  • Jiang X,Zhou J,Yuen NK,Corless CL,Heinrich MC,Fletcher JA,Demetri GD,Widlund HR,Fisher DE,Hodi FS.Imatinib targeting of KIT-mutant oncoprotein in melanoma.Clin Cancer Res. 2008 Dec 1;14(23):7726-32.
    19047099
  • Heinrich MC,Maki RG,Corless CL,Antonescu CR,Harlow A,Griffith D,Town A,McKinley A,Ou WB,Fletcher JA,Fletcher CD,Huang X,Cohen DP,Baum CM,Demetri GD.Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor.J Clin Oncol. 2008 Nov 20;26(33):5352-9.
    18955458
  • Heinrich MC,Owzar K,Corless CL,Hollis D,Borden EC,Fletcher CD,Ryan CW,von Mehren M,Blanke CD,Rankin C,Benjamin RS,Bramwell VH,Demetri GD,Bertagnolli MM,Fletcher JA.Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group.J Clin Oncol. 2008 Nov 20;26(33):5360-7.
    18955451
  • French CA,Fletcher JA,Cibas ES,Caulfield C,Allard P,Kroll TG.Molecular detection of PPAR gamma rearrangements and thyroid carcinoma in preoperative fine-needle aspiration biopsies.Endocr Pathol. 2008 Fall;19(3):166-74.
    18688583
  • Heinrich MC, Joensuu H, Demetri GD, Corless CL, Apperley J, Fletcher JA, Soulieres D, Dirnhofer S, Harlow A, Town A, McKinley A, Supple SG, Seymour J, Di Scala L, van Oosterom A, Herrmann R, Nikolova Z, McArthur AG.Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases.Clin Cancer Res. 2008 May 1;14(9):2717-2725.
    18451237
  • French CA, Ramirez CL, Kolmakova J, Hickman TT, Cameron MJ, Thyne ME, Kutok JL, Toretsky JA, Tadavarthy AK, Kees UR, Fletcher JA, Aster JC.BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.Oncogene. 2008 Apr 3;27(15):2237-42.
    17934517
  • Blanke CD, Demetri GD, von Mehren M, Heinrich MC, Eisenberg B, Fletcher JA, Corless CL, Fletcher CD, Roberts PJ, Heinz D, Wehre E, Nikolova Z, Joensuu H.Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT.J Clin Oncol. 2008 Feb 1;26(4):620-5.
    18235121
  • Janeway KA, Liegl B, Harlow A, Le C, Perez-Atayde A, Kozakewich H, Corless CL, Heinrich MC, Fletcher JA.Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.Cancer Res. 2007 Oct 1;67(19):9084-8.
    17909012
  • Zhu MJ, Ou WB, Fletcher CD, Cohen PS, Demetri GD, Fletcher JA.KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance.Oncogene. 2007 Sep 27;26(44):6386-95.
    17452978
  • Desai J, Shankar S, Heinrich MC, Fletcher JA, Fletcher CD, Manola J, Morgan JA, Corless CL, George S, Tuncali K, Silverman SG, Van den Abbeele AD, van Sonnenberg E, Demetri GD.Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors.Clin Cancer Res. 2007 Sep 15;13(18 Pt 1):5398-405.
    17875769
  • Schmidt J, Derr V, Heinrich MC, Crum CP, Fletcher JA, Corless CL, Nose V.BRAF in papillary thyroid carcinoma of ovary (struma ovarii).Am J Surg Pathol. 2007 Sep;31(9):1337-43.
    17721188
  • Grosso F, Jones RL, Demetri GD, Judson IR, Blay JY, Le Cesne A, Sanfilippo R, Casieri P, Collini P, Dileo P, Spreafico C, Stacchiotti S, Tamborini E, Tercero JC, Jimeno J, D'Incalci M, Gronchi A, Fletcher JA, Pilotti S, Casali PG.Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study.Lancet Oncol. 2007 Jul;8(7):595-602.
    17586092
  • Huang J, Zhao YL, Li Y, Fletcher JA, Xiao S.Genomic and functional evidence for an ARID1A tumor suppressor role.Genes Chromosomes Cancer. 2007 Aug;46(8):745-50.
    17492758
  • Bauer S, Duensing A, Demetri GD, Fletcher JA.KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway.Oncogene. 2007 Nov 29;26(54):7560-8.
    17546049
  • Nucci MR, Drapkin R, Cin PD, Fletcher CD, Fletcher JA.Distinctive Cytogenetic Profile in Benign Metastasizing Leiomyoma: Pathogenetic Implications.Am J Surg Pathol. 2007 May;31(5):737-743.
    17460458
  • Chang BS, Yang T, Cibas ES, Fletcher JA.An in vitro cytologic assay for evaluation of the KIT signaling pathway in gastrointestinal stromal tumors.Mod Pathol. 2007 May;20(5):579-83.
    17396139
  • Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, Macconnaill LE, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, Majmudar K, Ziaugra L, Wong KK, Gabriel S, Beroukhim R, Peyton M, Barretina J, Dutt A, Emery .Corrigendum: High-throughput oncogene mutation profiling in human cancer.Nat Genet. 2007 Apr;39(4):567.
    17392811
  • Liu Y, Tseng M, Perdreau SA, Rossi F, Antonescu C, Besmer P, Fletcher JA, Duensing S, Duensing A.Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate.Cancer Res. 2007 Mar 15;67(6):2685-92.
    17363589
  • Li Y, Chang Q, Rubin BP, Fletcher CD, Morgan TW, Mentzer SJ, Sugarbaker DJ, Fletcher JA, Xiao S.Insulin receptor activation in solitary fibrous tumours.J Pathol. 2007 Apr;211(5):550-4.
    17299733
  • Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM, Wang M, Feng W, Zander T, MacConaill L, Lee JC, Nicoletti R, Hatton C, Goyette M, Girard L, Majmudar K, Ziaugra L, Wong KK, Gabriel S, Beroukhim R, Peyton M, Barretina J, Dutt A, Emery C, Greulich H, Shah K, Sasaki H, Gazdar A, Minna J, Armstrong SA, Mellinghoff IK, Hodi FS, Dranoff G, Mischel PS, Cloughesy TF, Nelson SF, Liau LM, Mertz K, Rubin MA, Moch H, Loda M, Catalona W, Fletcher J, Signoretti S, Kaye F, Anderson KC, Demetri GD, Dummer R, Wagner S, Herlyn M, Sellers WR, Meyerson M, Garraway LA.High-throughput oncogene mutation profiling in human cancer.Nat Genet. 2007 Mar;39(3):347-351.
    17293865
  • Fletcher JA, Rubin BP.KIT mutations in GIST.Curr Opin Genet Dev. 2007 Feb;17(1):3-7. Review.
    17208434
  • Bauer S, Yu LK, Demetri GD, Fletcher JA.Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor.Cancer Res. 2006 Sep 15;66(18):9153-61.
    16982758
  • Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, Eisenberg BL, von Mehren M, Fletcher CD, Sandau K, McDougall K, Ou WB, Chen CJ, Fletcher JA.Molecular correlates of imatinib resistance in gastrointestinal stromal tumors.J Clin Oncol. 2006 Oct 10;24(29):4764-74.
    16954519
  • Rezk S, Wheelock L, Fletcher JA, Oliveira AM, Keuker CP, Newburger PE, Xu B, Woda BA, Miron PM.Acute lymphocytic leukemia with eosinophilia and unusual karyotype.Leuk Lymphoma. 2006 Jun;47(6):1176-9.
    16840218
  • Rossi S, Ou W, Tang D, Bhattacharya N, Dei Tos A, Fletcher J, Loda M.Gastrointestinal stromal tumours overexpress fatty acid synthase.J Pathol. 2006 Jul;209(3):369-75.
    16583360
  • Davis IJ, Kim JJ, Ozsolak F, Widlund HR, Rozenblatt-Rosen O, Granter SR, Du J, Fletcher JA, Denny CT, Lessnick SL, Linehan WM, Kung AL, Fisher DE.Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.Cancer Cell. 2006 Jun;9(6):473-84.
    16766266
  • Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, Hirte H, Cresta S, Koslin DB, Corless CL, Dirnhofer S, van Oosterom AT, Nikolova Z, Dimitrijevic S, Fletcher JA.Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor).J Clin Oncol. 2006 Mar 1;24(7):1195-203.
    16505440
  • Oliveira AM, Ross JS, Fletcher JA.Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers.Am J Clin Pathol. 2005 Dec;124 Suppl:S16-28. Review.
    16468415
  • Brock JE, Perez-Atayde AR, Kozakewich HP, Richkind KE, Fletcher JA, Vargas SO.Cytogenetic aberrations in perineurioma: variation with subtype.Am J Surg Pathol. 2005 Sep;29(9):1164-9.
    16096405
  • Li FP, Fletcher JA, Heinrich MC, Garber JE, Sallan SE, Curiel-Lewandrowski C, Duensing A, van de Rijn M, Schnipper LE, Demetri GD.Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.J Clin Oncol. 2005 Apr 20;23(12):2735-43.
    15837988
  • Labropoulos SV, Fletcher JA, Oliveira AM, Papadopoulos S, Razis ED.Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate.Anticancer Drugs. 2005 Apr;16(4):461-6.
    15746584
  • Oliveira AM, Perez-Atayde AR, Dal Cin P, Gebhardt MC, Chen CJ, Neff JR, Demetri GD, Rosenberg AE, Bridge JA, Fletcher JA.Aneurysmal bone cyst variant translocations upregulate USP6 transcription by promoter swapping with the ZNF9, COL1A1, TRAP150, and OMD genes.Oncogene. 2005 May 12;24(21):3419-26.
    15735689
  • McArthur GA, Demetri GD, van Oosterom A, Heinrich MC, Debiec-Rychter M, Corless CL, Nikolova Z, Dimitrijevic S, Fletcher JA.Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.J Clin Oncol. 2005 Feb 1;23(4):866-73.
    15681532
  • Oliveira AM, Perez-Atayde AR, Inwards CY, Medeiros F, Derr V, Hsi BL, Gebhardt MC, Rosenberg AE, Fletcher JA.USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts.Am J Pathol. 2004 Nov;165(5):1773-80.
    15509545
  • Price VE, Fletcher JA, Zielenska M, Cole W, Viero S, Manson DE, Stuart M, Pappo AS.Imatinib mesylate: an attractive alternative in young children with large, surgically challenging dermatofibrosarcoma protuberans.Pediatr Blood Cancer. 2005 May;44(5):511-5.
    15503291
  • Chen J, Deangelo DJ, Kutok JL, Williams IR, Lee BH, Wadleigh M, Duclos N, Cohen S, Adelsperger J, Okabe R, Coburn A, Galinsky I, Huntly B, Cohen PS, Meyer T, Fabbro D, Roesel J, Banerji L, Griffin JD, Xiao S, Fletcher JA, Stone RM, Gilliland DG.PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder.Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14479-84.
    15448205
  • Duensing A, Joseph NE, Medeiros F, Smith F, Hornick JL, Heinrich MC, Corless CL, Demetri GD, Fletcher CD, Fletcher JA.Protein Kinase C theta (PKCtheta) expression and constitutive activation in gastrointestinal stromal tumors (GISTs).Cancer Res. 2004 Aug 1;64(15):5127-31.
    15289315
  • Medeiros F, Corless CL, Duensing A, Hornick JL, Oliveira AM, Heinrich MC, Fletcher JA, Fletcher CD.KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications.Am J Surg Pathol. 2004 Jul;28(7):889-94.
    15223958
  • Fletcher JA.Molecular biology and cytogenetics of soft tissue sarcomas: relevance for targeted therapies.Cancer Treat Res. 2004;120:99-116.
    15217220
  • Fletcher JA.Role of KIT and platelet-derived growth factor receptors as oncoproteins.Semin Oncol. 2004 Apr;31(2 Suppl 6):4-11.
    15175998
  • Rubin MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer MD, Storz-Schweizer M, Kuefer R, Fletcher JA, Hsi BL, Byrne JA, Pienta KJ, Collins C, Sellers WR, Chinnaiyan AM.Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer.Cancer Res. 2004 Jun 1;64(11):3814-22.
    15172988
  • Panagopoulos I, Storlazzi CT, Fletcher CD, Fletcher JA, Nascimento A, Domanski HA, Wejde J, Brosj O, Rydholm A, Isaksson M, Mandahl N, Mertens F.The chimeric FUS/CREB3l2 gene is specific for low-grade fibromyxoid sarcoma.Genes Chromosomes Cancer. 2004 Jul;40(3):218-28.
    15139001
  • Dahln A, Fletcher CD, Mertens F, Fletcher JA, Perez-Atayde AR, Hicks MJ, Debiec-Rychter M, Sciot R, Wejde J, Wedin R, Mandahl N, Panagopoulos I.Activation of the GLI oncogene through fusion with the beta-actin gene (ACTB) in a group of distinctive pericytic neoplasms: pericytoma with t(7;12).Am J Pathol. 2004 May;164(5):1645-53.
    15111311
  • Oliveira AM, Hsi BL, Weremowicz S, Rosenberg AE, Dal Cin P, Joseph N, Bridge JA, Perez-Atayde AR, Fletcher JA.USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst.Cancer Res. 2004 Mar 15;64(6):1920-3.
    15026324
  • Duensing A, Medeiros F, McConarty B, Joseph NE, Panigrahy D, Singer S, Fletcher CD, Demetri GD, Fletcher JA.Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs).Oncogene. 2004 May 13;23(22):3999-4006.
    15007386
  • Kemmer K, Corless CL, Fletcher JA, McGreevey L, Haley A, Griffith D, Cummings OW, Wait C, Town A, Heinrich MC.KIT mutations are common in testicular seminomas.Am J Pathol. 2004 Jan;164(1):305-13.
    14695343
  • Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S, Fletcher JA.Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.J Clin Oncol. 2003 Dec 1;21(23):4342-9.
    14645423
  • Davis IJ, Hsi BL, Arroyo JD, Vargas SO, Yeh YA, Motyckova G, Valencia P, Perez-Atayde AR, Argani P, Ladanyi M, Fletcher JA, Fisher DE.Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation.Proc Natl Acad Sci U S A. 2003 May 13;100(10):6051-6.
    12719541
  • Haralambieva E, Banham AH, Bastard C, Delsol G, Gaulard P, Ott G, Pileri S, Fletcher JA, Mason DY.Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples.Br J Haematol. 2003 Apr;121(1):49-56.
    12670331
  • French CA, Alexander EK, Cibas ES, Nose V, Laguette J, Faquin W, Garber J, Moore F, Fletcher JA, Larsen PR, Kroll TG.Genetic and biological subgroups of low-stage follicular thyroid cancer.Am J Pathol. 2003 Apr;162(4):1053-60.
    12651598
  • Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML, Pieters R, Kersey JH, Sallan SE, Fletcher JA, Golub TR, Griffin JD, Korsmeyer SJ.Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification.Cancer Cell. 2003 Feb;3(2):173-83.
    12620411
  • French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA.BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma.Cancer Res. 2003 Jan 15;63(2):304-7.
    12543779
  • Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, Singer S, Griffith DJ, Haley A, Town A, Demetri GD, Fletcher CD, Fletcher JA.PDGFRA activating mutations in gastrointestinal stromal tumors.Science. 2003 Jan 31;299(5607):708-10.
    12522257
  • Chang Q, Li Y, White MF, Fletcher JA, Xiao S.Constitutive activation of insulin receptor substrate 1 is a frequent event in human tumors: therapeutic implications.Cancer Res. 2002 Nov 1;62(21):6035-8.
    12414625
  • Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CD, Joensuu H.Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.N Engl J Med. 2002 Aug 15;347(7):472-80.
    12181401
  • Heinrich MC, Rubin BP, Longley BJ, Fletcher JA.Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations.Hum Pathol. 2002 May;33(5):484-95.
    12094373
  • Vargas SO, Nos V, Fletcher JA, Perez-Atayde AR.Gains of chromosome 8 are confined to mesenchymal components in pleuropulmonary blastoma.Pediatr Dev Pathol. 2001 Sep-Oct;4(5):434-45.
    11779045
  • French CA, Miyoshi I, Aster JC, Kubonishi I, Kroll TG, Dal Cin P, Vargas SO, Perez-Atayde AR, Fletcher JA.BRD4 bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19).Am J Pathol. 2001 Dec;159(6):1987-92.
    11733348
  • Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, Demetri GD, Fletcher CD, Fletcher JA.KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.Cancer Res. 2001 Nov 15;61(22):8118-21.
    11719439
  • Vargas SO, French CA, Faul PN, Fletcher JA, Davis IJ, Dal Cin P, Perez-Atayde AR.Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course.Cancer. 2001 Sep 1;92(5):1195-203.
    11571733
  • Gisselsson D, Hibbard MK, Dal Cin P, Sciot R, Hsi BL, Kozakewich HP, Fletcher JA.PLAG1 alterations in lipoblastoma: involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms.Am J Pathol. 2001 Sep;159(3):955-62.
    11549588
  • Steele-Perkins G, Fang W, Yang XH, Van Gele M, Carling T, Gu J, Buyse IM, Fletcher JA, Liu J, Bronson R, Chadwick RB, de la Chapelle A, Zhang X, Speleman F, Huang S.Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily.Genes Dev. 2001 Sep 1;15(17):2250-62.
    11544182
  • Tuveson DA, Willis NA, Jacks T, Griffin JD, Singer S, Fletcher CD, Fletcher JA, Demetri GD.STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications.Oncogene. 2001 Aug 16;20(36):5054-8.
    11526490
  • Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF, Newbury R, Reuter VE, Garvin AJ, Perez-Atayde AR, Fletcher JA, Beckwith JB, Bridge JA, Ladanyi M.Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents.Am J Pathol. 2001 Jul;159(1):179-92.
    11438465
  • Tuveson DA, Fletcher JA.Signal transduction pathways in sarcoma as targets for therapeutic intervention.Curr Opin Oncol. 2001 Jul;13(4):249-55.
    11429482
  • Koontz JI, Soreng AL, Nucci M, Kuo FC, Pauwels P, van Den Berghe H, Cin PD, Fletcher JA, Sklar J.Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors.Proc Natl Acad Sci U S A. 2001 May 22;98(11):6348-53.
    11371647
  • Lee C, Gisselsson D, Jin C, Nordgren A, Ferguson DO, Blennow E, Fletcher JA, Morton CC.Limitations of chromosome classification by multicolor karyotyping.Am J Hum Genet. 2001 Apr;68(4):1043-7.
    11222105
  • Aguiar RC, Yakushijin Y, Kharbanda S, Salgia R, Fletcher JA, Shipp MA.BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.Blood. 2000 Dec 15;96(13):4328-34.
    11110709
  • Zhao J, Kennedy BK, Lawrence BD, Barbie DA, Matera AG, Fletcher JA, Harlow E.NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription.Genes Dev. 2000 Sep 15;14(18):2283-97.
    10995386
  • Kroll TG, Sarraf P, Pecciarini L, Chen CJ, Mueller E, Spiegelman BM, Fletcher JA.PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].Science. 2000 Aug 25;289(5483):1357-60.
    10958784
  • Xiao S, McCarthy JG, Aster JC, Fletcher JA.ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain.Blood. 2000 Jul 15;96(2):699-704.
    10887137
  • Lux ML, Rubin BP, Biase TL, Chen CJ, Maclure T, Demetri G, Xiao S, Singer S, Fletcher CD, Fletcher JA.KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.Am J Pathol. 2000 Mar;156(3):791-5.
    10702394
  • Morgan JA, Yin Y, Borowsky AD, Kuo F, Nourmand N, Koontz JI, Reynolds C, Soreng L, Griffin CA, Graeme-Cook F, Harris NL, Weisenburger D, Pinkus GS, Fletcher JA, Sklar J.Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18.Cancer Res. 1999 Dec 15;59(24):6205-13.
    10626814
  • Rubin BP, Fletcher JA, Renshaw AA.Clear cell sarcoma of soft parts: report of a case primary in the kidney with cytogenetic confirmation.Am J Surg Pathol. 1999 May;23(5):589-94.
    10328092
  • Millis K, Weybright P, Campbell N, Fletcher JA, Fletcher CD, Cory DG, Singer S.Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy.Magn Reson Med. 1999 Feb;41(2):257-67.
    10080272
  • Davison JM, Morgan TW, Hsi BL, Xiao S, Fletcher JA.Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications.Am J Pathol. 1998 Nov;153(5):1401-9.
    9811331
  • Rubin BP, Chen CJ, Morgan TW, Xiao S, Grier HE, Kozakewich HP, Perez-Atayde AR, Fletcher JA.Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.Am J Pathol. 1998 Nov;153(5):1451-8.
    9811336
  • Jones D, Ballestas ME, Kaye KM, Gulizia JM, Winters GL, Fletcher J, Scadden DT, Aster JC.Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient.N Engl J Med. 1998 Aug 13;339(7):444-9.
    9700178
  • Xiao S, Nalabolu SR, Aster JC, Ma J, Abruzzo L, Jaffe ES, Stone R, Weissman SM, Hudson TJ, Fletcher JA.FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.Nat Genet. 1998 Jan;18(1):84-7.
    9425908
  • Xiao S, Lux ML, Reeves R, Hudson TJ, Fletcher JA.HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma.Am J Pathol. 1997 Mar;150(3):901-10.
    9060828
  • Tontonoz P, Singer S, Forman BM, Sarraf P, Fletcher JA, Fletcher CD, Brun RP, Mueller E, Altiok S, Oppenheim H, Evans RM, Spiegelman BM.Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.Proc Natl Acad Sci U S A. 1997 Jan 7;94(1):237-41.
    8990192
  • Hoffer FA, Chung T, Diller L, Kozakewich H, Fletcher JA, Shamberger RC.Percutaneous biopsy for prognostic testing of neuroblastoma.Radiology. 1996 Jul;200(1):213-6.
    8657913
  • Xiao S, Li D, Corson JM, Vijg J, Fletcher JA.Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma.Cancer Res. 1995 Jul 15;55(14):2968-71.
    7606711
  • Naeem R, Singer S, Fletcher JA.Translocation t(8;13)(p11;q11-12) in stem cell leukemia/lymphoma of T-cell and myeloid lineages.Genes Chromosomes Cancer. 1995 Feb;12(2):148-51.
    7535088
  • Weremowicz S, Kozakewich HP, Haber D, Park S, Morton CC, Fletcher JA.Identification of genetically aberrant cell lineages in Wilms' tumors.Genes Chromosomes Cancer. 1994 May;10(1):40-8.
    7519872
  • Fletcher JA, Kozakewich HP, Schoenberg ML, Morton CC.Cytogenetic findings in pediatric adipose tumors: consistent rearrangement of chromosome 8 in lipoblastoma.Genes Chromosomes Cancer. 1993 Jan;6(1):24-9.
    7680218
  • Fletcher JA, Pinkus GS, Donovan K, Naeem R, Sugarbaker DJ, Mentzer S, Pinkus JL, Longtine J.Clonal rearrangement of chromosome band 6p21 in the mesenchymal component of pulmonary chondroid hamartoma.Cancer Res. 1992 Nov 15;52(22):6224-8.
    1423265
  • Fletcher JA, Pinkus JL, Lage JM, Morton CC, Pinkus GS.Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp.Genes Chromosomes Cancer. 1992 Oct;5(3):260-3.
    1384681
  • Fletcher JA, Henkle C, Atkins L, Rosenberg AE, Morton CC.Trisomy 5 and trisomy 7 are nonrandom aberrations in pigmented villonodular synovitis: confirmation of trisomy 7 in uncultured cells.Genes Chromosomes Cancer. 1992 Apr;4(3):264-6.
    1382569
  • Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, Pinkus GS, Morton CC, Corson JM.Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors.N Engl J Med. 1991 Feb 14;324(7):436-42.
    1988828